Spasmodic Dysphonia  >>  sodium oxybate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium oxybate / Generic mfg.
NCT01961297: Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response

Completed
2
53
US
Sodium oxybate, Xyrem
Kristina Simonyan, National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)
Spasmodic Dysphonia, Voice Tremor
06/17
06/17

Download Options